Virtu Financial LLC Royalty Pharma PLC Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$26.21 - $29.22 $120,854 - $134,733	4,611 Added 49.7%	13,888 $390,000
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $455,847 - $544,725	-17,359 Reduced 65.17%	9,277 $252,000
Q2 2023 Jul 27, 2023	BUY	$29.6 - $36.56 $788,425 - $973,812	26,636 New	26,636 $819,000
Q4 2022 Feb 15, 2023	BUY	$39.17 - $44.04 $16,333 - $18,364	417 Added 5.8%	7,604 $300,000
Q3 2022 Nov 07, 2022	BUY	$39.88 - $44.65 $286,617 - $320,899	7,187 New	7,187 $289,000
Q4 2021 Feb 17, 2022	SELL	$35.17 - $42.48 $345,826 - $417,705	-9,833 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $505,743 - $591,106	-13,994 Reduced 58.73%	9,833 $355,000
Q2 2021 Sep 17, 2021	BUY	$39.85 - $46.63 $949,505 - $1.11 Million	23,827 New	23,827 $977,000
Q3 2020 Dec 11, 2020	SELL	$38.56 - $48.36 $242,889 - $304,619	-6,299 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$44.5 - $52.11 $280,305 - $328,240	6,299 New	6,299 $306,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.